chrX-137030751-C-G

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_054021.2(GPR101):​c.924G>C​(p.Glu308Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00476 in 1,209,166 control chromosomes in the GnomAD database, including 15 homozygotes. There are 1,903 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E308K) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0034 ( 1 hom., 91 hem., cov: 22)
Exomes 𝑓: 0.0049 ( 14 hom. 1812 hem. )

Consequence

GPR101
NM_054021.2 missense

Scores

1
16

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:1B:4O:1

Conservation

PhyloP100: -1.90

Publications

28 publications found
Variant links:
Genes affected
GPR101 (HGNC:14963): (G protein-coupled receptor 101) The protein encoded by this gene is an orphan G protein-coupled receptor of unknown function. The encoded protein is a member of a family of proteins that contain seven transmembrane domains and transduce extracellular signals through heterotrimeric G proteins. [provided by RefSeq, Sep 2011]
GPR101 Gene-Disease associations (from GenCC):
  • pituitary adenoma, growth hormone-secreting, 2
    Inheritance: XL Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • acromegaly
    Inheritance: Unknown Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.004725307).
BP6
Variant X-137030751-C-G is Benign according to our data. Variant chrX-137030751-C-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 167871.
BS2
High Hemizygotes in GnomAd4 at 91 XL,Unknown gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GPR101NM_054021.2 linkc.924G>C p.Glu308Asp missense_variant Exon 2 of 2 ENST00000651716.2 NP_473362.1 Q96P66

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GPR101ENST00000651716.2 linkc.924G>C p.Glu308Asp missense_variant Exon 2 of 2 NM_054021.2 ENSP00000498972.1 Q96P66

Frequencies

GnomAD3 genomes
AF:
0.00344
AC:
382
AN:
110993
Hom.:
1
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.000690
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00104
Gnomad ASJ
AF:
0.00949
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00117
Gnomad FIN
AF:
0.00303
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00571
Gnomad OTH
AF:
0.00135
GnomAD2 exomes
AF:
0.00353
AC:
647
AN:
183283
AF XY:
0.00365
show subpopulations
Gnomad AFR exome
AF:
0.000380
Gnomad AMR exome
AF:
0.000729
Gnomad ASJ exome
AF:
0.00815
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00453
Gnomad NFE exome
AF:
0.00540
Gnomad OTH exome
AF:
0.00485
GnomAD4 exome
AF:
0.00489
AC:
5368
AN:
1098119
Hom.:
14
Cov.:
32
AF XY:
0.00499
AC XY:
1812
AN XY:
363479
show subpopulations
African (AFR)
AF:
0.000720
AC:
19
AN:
26403
American (AMR)
AF:
0.000625
AC:
22
AN:
35207
Ashkenazi Jewish (ASJ)
AF:
0.00882
AC:
171
AN:
19386
East Asian (EAS)
AF:
0.0000662
AC:
2
AN:
30206
South Asian (SAS)
AF:
0.00151
AC:
82
AN:
54143
European-Finnish (FIN)
AF:
0.00418
AC:
169
AN:
40453
Middle Eastern (MID)
AF:
0.00193
AC:
8
AN:
4137
European-Non Finnish (NFE)
AF:
0.00557
AC:
4688
AN:
842089
Other (OTH)
AF:
0.00449
AC:
207
AN:
46095
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
238
475
713
950
1188
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
172
344
516
688
860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00344
AC:
382
AN:
111047
Hom.:
1
Cov.:
22
AF XY:
0.00274
AC XY:
91
AN XY:
33259
show subpopulations
African (AFR)
AF:
0.000688
AC:
21
AN:
30503
American (AMR)
AF:
0.00104
AC:
11
AN:
10553
Ashkenazi Jewish (ASJ)
AF:
0.00949
AC:
25
AN:
2633
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3511
South Asian (SAS)
AF:
0.00117
AC:
3
AN:
2562
European-Finnish (FIN)
AF:
0.00303
AC:
18
AN:
5950
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
217
European-Non Finnish (NFE)
AF:
0.00571
AC:
302
AN:
52926
Other (OTH)
AF:
0.00133
AC:
2
AN:
1504
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
15
30
46
61
76
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00285
Hom.:
23
Bravo
AF:
0.00323
TwinsUK
AF:
0.00593
AC:
22
ALSPAC
AF:
0.00450
AC:
13
ExAC
AF:
0.00360
AC:
437
EpiCase
AF:
0.00545
EpiControl
AF:
0.00486

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:1Benign:4Other:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Pituitary adenoma, growth hormone-secreting, 2 Pathogenic:1Uncertain:1Other:1
May 28, 2019
Mendelics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 26, 2015
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

-
GeneReviews
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

- -

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

GPR101-related disorder Benign:1
Mar 03, 2020
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.083
BayesDel_addAF
Benign
-0.71
T
BayesDel_noAF
Benign
-0.79
CADD
Benign
0.19
DANN
Benign
0.41
DEOGEN2
Benign
0.0026
T
FATHMM_MKL
Benign
0.032
N
LIST_S2
Benign
0.38
T
M_CAP
Uncertain
0.18
D
MetaRNN
Benign
0.0047
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.69
N
PhyloP100
-1.9
PrimateAI
Benign
0.25
T
PROVEAN
Benign
-0.53
N
REVEL
Benign
0.028
Sift
Benign
0.13
T
Sift4G
Benign
0.068
T
Polyphen
0.0010
B
Vest4
0.033
MutPred
0.18
Gain of glycosylation at S309 (P = 0.1215);
MVP
0.51
MPC
0.43
ClinPred
0.0029
T
GERP RS
-5.2
Varity_R
0.057
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs73637412; hg19: chrX-136112910; COSMIC: COSV53238460; API